Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models

Malignant soft tissue tumors, particularly highly malignant leiomyosarcomas, are resistant to chemotherapy and associated with a poor prognosis. T-01, a third-generation genetically modified herpes simplex virus type 1, replicates in tumor cells alone and exerts a cell-killing effect. The current st...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatta, Masahiko, Kaibori, Masaki, Matsushima, Hideyuki, Yoshida, Terufumi, Okumura, Tadayoshi, Hayashi, Mikio, Yoshii, Kengo, Todo, Tomoki, Sekimoto, Mitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118137/
https://www.ncbi.nlm.nih.gov/pubmed/35615265
http://dx.doi.org/10.1016/j.omto.2022.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118137/
https://www.ncbi.nlm.nih.gov/pubmed/35615265
http://dx.doi.org/10.1016/j.omto.2022.04.010

Ejemplares similares